About the Company
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis (MS) or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk. Ekso Bionics currently focuses in the health and industrial sectors. The company's first commercially available health product was called EksoGT (formerly eLEGS). Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Ekso was selected as Wired magazine's number two "Most Significant Gadget of 2010", and was included in Time magazine's "50 Best Innovations of 2010". Ekso Bionics was also featured in Inc. magazine as one of "5 Big Ideas for the Next 15 Years".
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $EKSO News
Ekso Bionics Holdings Inc
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2023 Earnings Call Transcript
Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.22 EPS, expectations were $-0.11. EKSO isn’t one of the 30 most popular stocks among hedge funds at the end of ...
EKSO Apr 2024 5.000 call
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2023 Earnings Call Transcript March 4, 2024 Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.22 EPS, expectations were ...
Ekso Bionics: Q4 Earnings Snapshot
SAN RAFAEL, Calif. (AP) — SAN RAFAEL, Calif. (AP) — Ekso Bionics Holdings Inc. (EKSO) on Monday reported a loss of $3.2 million in its fourth quarter. On a per-share basis, the San Rafael ...
Ekso Bionics Holdings Inc EKSO
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2023 Earnings Call Transcript
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2023 Earnings Call Transcript March 4, 2024 Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.22 EPS, expectations were ...
Ekso Bionics Holdings Inc (EKSO)
In a recent move, Lathan Corinna, a director at Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), has made a series of share purchases, signaling confidence in the company's future ...
Ekso Bionics Holdings Inc.
1 Day EKSO -4.70% DJIA 1.22% Russell 2K 2.13% Health Care/Life Sciences 0.06% ...
Ekso Bionics Holdings Inc
Invest with your heart and your phone with as little as $1 with these ESG and socially responsible investing apps.
Ekso Bionics Holdings Inc (23E2.MU)
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2023 Earnings Call Transcript March 4, 2024 Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.22 EPS, expectations were ...
Loading the latest forecasts...